Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 22510871

Safety and efficacy of brentuximab vedotin for Hodgkin lymphoma recurring after allogeneic stem cell transplantation.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Blood
Publication date
2012 Jul 19
First author
Gopal AK

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Gopal AK
      type
      Author
    2. name
      Ramchandren R
      type
      Author
    3. name
      O'Connor OA
      type
      Author
    4. name
      Berryman RB
      type
      Author
    5. name
      Advani RH
      type
      Author
    6. name
      Chen R
      type
      Author
    7. name
      Smith SE
      type
      Author
    8. name
      Cooper M
      type
      Author
    9. name
      Rothe A
      type
      Author
    10. name
      Matous JV
      type
      Author
    11. name
      Grove LE
      type
      Author
    12. name
      Zain J
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Gopal AK
      type
      Author
    2. name
      Ramchandren R
      type
      Author
    3. name
      O'Connor OA
      type
      Author
    4. name
      Berryman RB
      type
      Author
    5. name
      Advani RH
      type
      Author
    6. name
      Chen R
      type
      Author
    7. name
      Smith SE
      type
      Author
    8. name
      Cooper M
      type
      Author
    9. name
      Rothe A
      type
      Author
    10. name
      Matous JV
      type
      Author
    11. name
      Grove LE
      type
      Author
    12. name
      Zain J
      type
      Author
    bibliography ids
    1. nci-bib-c6e73a4266c1daf9feded9db
    book metadata
    content sha256
    db009b6b3ff9f873d6965e2e83f747ac6f12ca84f8727eccbd846247fa97542e
    document type
    citation
    dois
    1. 10.1182/blood-2011-12-397893
    electronic publication date
    display
    2012 Apr 17
    precision
    day
    year
    2012
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:22510871
    immutable id
    pubmed:22510871@db009b6b3ff9f873d6965e2e83f747ac6f12ca84f8727eccbd846247fa97542e
    journal
    abbreviation
    Blood
    issn electronic
    1528-0020
    issn print
    0006-4971
    issue
    3
    name
    Blood
    nlm unique id
    7603509
    pages
    560-8
    volume
    120
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      22510871
      provenance
      batch id
      c95be1d0b8cf19942816
      provider
      NCBI PubMed ESummary
      record sha256
      2e5572cc905875508d7f96109008263ea92f4a231536c2f99d99b12fd307d174
      response sha256
      a96bb680a8f3690267e009557d1b07aab71455ba44aeba18695d98a3eeb5fcf2
      retrieved at
      2026-09-09T23:46:47.691937+00:00
      publication date
      display
      2012 Jul 19
      precision
      day
      year
      2012
      publication types
      1. Clinical Trial
      2. Journal Article
      3. Multicenter Study
      4. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/22510871/
      title
      Safety and efficacy of brentuximab vedotin for Hodgkin lymphoma recurring after allogeneic stem cell transplantation.

      Preserved source evidence · Not medical advice